Coverage
-
May 19, 2023
A jury found the CEO of a Miami clinical drug trial company and an employee not guilty on Thursday of all charges connected to an alleged scheme to falsify research and defraud drugmakers, although it did convict a third defendant of making false statements.
1 other articles on this case.
View all »